Active03870943Private limited companyRedcar

EVEREST BIOTECH LIMITED

Significant control: Everest Biotech Holdings Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Everest Biotech Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Everest Biotech Limited sell?

Registered activity: Other manufacturing n.e.c. (SIC 32990). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

EVEREST BIOTECH LIMITED is an active private limited company (company number 03870943) incorporated on 3 November 1999, registered in Redcar. Its registered activity is other manufacturing n.e.c. (SIC 32990). Latest small accounts cover the period ending 31 December 2024, showing net assets of £2.37m and cash of £386k, with 5 employees on average. Net assets rose 10% on the prior period (£2.15m).

Peer position · net assets

By net assets it sits in the top quarter of 92 comparable companies in Teesside (median £3,186, upper quartile £94k).

02

Ownership and control

1 active · 4 other
  • Everest Biotech Holdings Limited
    corporate entity, England · since 5 November 2025
    • owns 75–100% of shares
  • Mr Garfield Collins
    Individual · since 6 April 2016 · ceased 5 July 2018
    • owns 25–50% of shares
  • persons with significant control statement · since 7 July 2018 · ceased 6 January 2019
  • Mr Garfield Leslie Collins
    Individual · since 6 January 2019 · ceased 8 May 2019
    • owns 25–50% of shares
  • James Cooper
    Individual · since 8 May 2019 · ceased 5 November 2025
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
3 November 199926 yrs ago
Next accounts due
30 September 202628 days overdue
Confirmation statement due
17 November 2026in 20 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 32990
Other manufacturing n.e.c.
SIC 72110
Research and experimental development on biotechnology
Accounts type
Small
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
£2.37m
+10%vs Dec 2023
Cash at bank
£386k
+174%vs Dec 2023
Turnover
Not reported
Employees
5
No changevs Dec 2023
Net assets
£2.37m
Cash at bank
£386k
Average employees
5
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£2.37m£386k£2.49m£794k——5
31 December 2023£2.15m£141k£2.51m£881k——5
Current ratio3.98Current assets ÷ creditors within one year
Cash per employee£77kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £2,369,435 at 31 December 2024
  • Net assets up 10% or more on the prior period+10.4% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 3.98
  • Cash at bank of £50,000 or moreCash £386,488
  • Incorporated five or more years agoIncorporated 3 November 1999
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 20 days
  2. Next accounts due28 days overdue
  3. Accounts period endNet assets £2.37m · small accounts
  4. Accounts period endNet assets £2.15m · small accounts
  5. Incorporated
08

Similar companies in Teesside

Same activity (other manufacturing n.e.c.), closest in incorporation date
09

Reminders for EVEREST BIOTECH LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.